Trials / Unknown
UnknownNCT02157012
Evaluation of the Condition of Rheumatoid Arthritis After Treatment
Evaluation of the Condition After Xeljanz Treatment in Rheumatoid Arthritis Patients
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Shinshu University · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | The effectiveness of Xeljanz in rheumatoid arthritis patients |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2022-04-01
- Completion
- 2025-03-01
- First posted
- 2014-06-05
- Last updated
- 2021-09-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02157012. Inclusion in this directory is not an endorsement.